IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Sudeep Pharma IPO is a Book Building listing on BSE,NSE exchange, with an ipo size of ₹ [●] Cr. The company is based in Vadodara and caters to Advertising And Media sector. ICICI Securities , IIFL Securities are the merchant bankers of Sudeep Pharma IPO. It is a MainBoard Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 24th June 2025.
Sudeep Pharma IPO posted revenues of ₹ 459.27 crores and PAT of ₹ 126.05 crores in FY25 on annualised basis.
Revenue:
₹ 459.27 Cr.
EBITDA Margin:
39.70
% 
Net Worth: ₹ 449.70 Cr.
Market Capitalisation:
[●]
P/E:
[●]
P/BV: [●]
EV/EBITDA: [●]
Financial results of Sudeep Pharma IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | Dec-24 | FY24 | FY23 | FY22 | |
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 656.92 | 513.87 | 420.10 | 345.00 | |
| Net Worth | 449.70 | 355.99 | 223.28 | 162.80 | |
| Total Debt | 117.20 | 75.03 | 82.25 | 83.71 | |
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
344.45
459.27 |
459.28 | 428.74 | 344.62 | |
EBITDA
EBITDA on annualised basis |
136.74
182.32 |
187.75 | 142.74 | 130.19 | |
PAT
PAT on annualised basis |
94.54
126.05 |
187.75 | 62.32 | 49.80 | |
Sudeep Pharma IPO PAT Margin is 27.45 % , ROCE (Return on Capital Employed) is 22.61 % as per latest financial. The below table shows Sudeep Pharma IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | Dec-24 | FY24 | FY23 | FY22 |
|---|---|---|---|---|
| EBITDA Margin (%) | 39.70 | 40.88 | 33.29 | 37.78 |
| PAT Margin (%) | 27.45 | 40.88 | 14.54 | 14.45 |
| EPS (₹) | 8.71 | 12.27 | 5.74 | 4.59 |
| ROE (%) | 21.02 | 52.74 | 27.91 | 30.59 |
| ROCE (%) | 22.61 | 41.18 | 29.40 | 28.45 |
| ROA (%) | 14.39 | 36.54 | 14.83 | 14.43 |
| Debt to Equity | 0.26 | 0.21 | 0.37 | 0.51 |
The market Capitalisation of Sudeep Pharma IPO is ₹ [●] crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Sudeep Pharma IPO prospectus highlights an Return on Equity (ROE) of 21.02 % , Return on Assets (ROA) of 14.39 %, and an EBITDA Margin of 39.70 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Sudeep Pharma IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Sudeep Pharma IPO is ₹ [●] Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Sudeep Pharma IPO has a Price-to-Earnings (PE) ratio of [●], indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Sudeep Pharma IPO reported revenue of ₹ 459.27 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Sudeep Pharma IPO provide insights into sales growth, market demand, and business scalability.
Sudeep Pharma recorded an EBITDA of ₹ 182.32 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Sudeep Pharma Profit After Tax (PAT) is ₹ 126.05 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 459.27 Cr.
EBITDA Margin:
39.70
%
Net Worth: ₹ 449.70 Cr.
Market Capitalisation:
[●]
P/E:
[●]
P/BV: [●]
EV/EBITDA: [●]
Sudeep Pharma operates in Advertising And Media and Technology-led Manufacturer Specializing In Excipients And Specialty Ingredients For The Pharmaceutical, Food, And Nutrition Industries. The Issue is listed on BSE,NSE in Jun, 2025. Sudeep Pharma IPO size was with Issue price of .
Merchant Banker(s) of Sudeep Pharma IPO: ICICI Securities Limited , IIFL Securities Limited
Sudeep Pharma IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Sudeep Pharma IPO listed at a listing price of against the offer price of .
The current market price of Sudeep Pharma is .
Why Us?
